Hypofractionated Intensity-Modulated Radiation Therapy With Temozolomide and Bevacizumab for Glioblastoma Multiforme

NCT01209442 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme

Interventions

DRUG: Bevacizumab
DRUG: Temozolomide
RADIATION: RT (Radiation Therapy)

Sponsor

University of Colorado, Denver

Collaborators

[object Object]